Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and Head of Clinical Development Portfolio News / admin July 17, 2019 Escient Pharmaceuticals Appoints Kristin Taylor, PhD as Vice President and Head of Clinical Development Read More »
REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers Portfolio News / admin July 9, 2019 REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers Read More »
ORIC Pharmaceuticals Appoints Lori Friedman, PhD, as Chief Scientific Officer Portfolio News / admin July 9, 2019 ORIC Pharmaceuticals Appoints Lori Friedman, PhD, as Chief Scientific Officer Read More »
